Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
Weinshenker
B G
BG
CNS Department, University Hospital, London, Ontario, Canada.
Bass
B H
BH
Ebers
G C
GC
Rice
G P
GP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005121:Extremities; D005260:Female; D006801:Humans; D016853:Muromonab-CD3; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3